# TADALAFIL

NDC: 76420-546
Generic name: TADALAFIL
Labeler / Manufacturer: Asclemed USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20190326

FDA application: ANDA211839

## Active ingredients

- TADALAFIL: 5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"76420-546"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=76420-546
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=101f44e4-669c-4e3d-843a-a27157750f9c